Skip to main content
. 2013 Aug 23;27(11):943–953. doi: 10.1007/s40263-013-0102-x

Fig. 2.

Fig. 2

Patient selection: matching inclusion/exclusion criteria. aIndividual patients could have been included in more than one dose cohort where the dose ranges overlap. ADHD attention-deficit/hyperactivity disorder, ADHD-RS-IV ADHD Rating Scale IV, GXR guanfacine extended release, ITT intention-to-treat, SD standard deviation